Biovex Group, Inc.
Records under this name other than patents Biovex Group, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Biovex Group, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,223,593 | Herpes Virus Strains for Gene Therapy Formerly held Term ended Ended no later than Oct 28, 2026 · Medium confidence | Term ended | Ended no later than Oct 28, 2026 | Medium confidence |
| US 8,679,830 | Viral Vectors Formerly held Term ended Ended no later than Jan 4, 2026 · Medium confidence | Term ended | Ended no later than Jan 4, 2026 | Medium confidence |
| US 7,981,669 | Viral Vectors Formerly held Term ended Term ended Jul 26, 2024 · High confidence | Term ended | Term ended Jul 26, 2024 | High confidence |